{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["24(12)"],"submitter":["Bukhari A"],"pubmed_abstract":["<h4>Objectives</h4>Alpha-amylase and alpha-glucosidase enzyme inhibition is an effective and rational approach for controlling postprandial hyperglycemia in type II diabetes mellitus (DM). Several inhibitors of this therapeutic class are in clinical use but are facing challenges of safety, efficacy, and potency. Keeping in view the importance of these therapeutic inhibitors, in this study we are reporting 10 new oxadiazole analogs 5 (a-g) & 4a (a-c) as antidiabetic agents.<h4>Materials and methods</h4>The newly synthesized derivatives 5 (a-g) & 4a (a-c) were characterized using different spectroscopic techniques including FTIR,<sup>1</sup>HNMR, <sup>13</sup>CNMR, and elemental analysis data. All compounds were screened for their <i>in vitro</i> α-amylase and α-glucosidase enzyme inhibitory"],"journal":["Iranian journal of basic medical sciences"],"pagination":["1632-1642"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8976910"],"repository":["biostudies-literature"],"pubmed_title":["Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis, <i>in vitro</i> evaluation, and molecular docking studies."],"pmcid":["PMC8976910"],"pubmed_authors":["Imran M","Bukhari A","Nadeem H","Muhammad SA"],"additional_accession":[]},"is_claimable":false,"name":"Novel oxadiazole derivatives as potent inhibitors of α-amylase and α-glucosidase enzymes: Synthesis, <i>in vitro</i> evaluation, and molecular docking studies.","description":"<h4>Objectives</h4>Alpha-amylase and alpha-glucosidase enzyme inhibition is an effective and rational approach for controlling postprandial hyperglycemia in type II diabetes mellitus (DM). Several inhibitors of this therapeutic class are in clinical use but are facing challenges of safety, efficacy, and potency. Keeping in view the importance of these therapeutic inhibitors, in this study we are reporting 10 new oxadiazole analogs 5 (a-g) & 4a (a-c) as antidiabetic agents.<h4>Materials and methods</h4>The newly synthesized derivatives 5 (a-g) & 4a (a-c) were characterized using different spectroscopic techniques including FTIR,<sup>1</sup>HNMR, <sup>13</sup>CNMR, and elemental analysis data. All compounds were screened for their <i>in vitro</i> α-amylase and α-glucosidase enzyme inhibitory","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Dec","modification":"2025-04-26T13:09:09.771Z","creation":"2025-04-06T14:08:02.728Z"},"accession":"S-EPMC8976910","cross_references":{"pubmed":["35432813"],"doi":["10.22038/IJBMS.2021.58429.12977"]}}